keyword
https://read.qxmd.com/read/38187310/phenotype-guided-targeted-therapy-based-on-functional-signal-transduction-pathway-activity-in-recurrent-ovarian-cancer-patients-the-stapover-study-protocol
#21
JOURNAL ARTICLE
Phyllis van der Ploeg, Cynthia Se Hendrikse, Anna Mj Thijs, Hans M Westgeest, Huberdina Pm Smedts, M Caroline Vos, Mathilde Jalving, Christianne Ar Lok, Ingrid A Boere, Maaike Apc van Ham, Petronella B Ottevanger, Anneke M Westermann, Constantijne H Mom, Roy I Lalisang, Sandrina Lambrechts, Ruud Lm Bekkers, Jurgen Mj Piek
OBJECTIVE: Ovarian cancer is the fifth cause of cancer-related death among women. The benefit of targeted therapy for ovarian cancer patients is limited even if treatment is stratified by molecular signature. There remains a high unmet need for alternative diagnostics that better predict targeted therapy, as current diagnostics are generally inaccurate predictors. Quantitative assessment of functional signal transduction pathway (STP) activity from mRNA measurements of target genes is an alternative approach...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38178813/a-five-gene-qpcr-signature-can-classify-type-2-asthma-comparably-to-microscopy-of-induced-sputum-from-severe-asthma-patients
#22
JOURNAL ARTICLE
B Toennesen, J M Schmid, B S Sørensen, M Fricker, H J H Hoffmann
UNLABELLED: Asthma is a heterogenous disease characterized by airway inflammation and variable expiratory airflow limitation resulting in variable respiratory symptoms. Characterization of airway inflammation is important to choose the optimal treatment for severe asthma patients eligible for biological treatment. However, counting cells in induced sputum samples are a time-consuming process, highly dependent on personal skills. Replacing eosinophil and neutrophil cell counting with qPCR for transcripts of selected mast cell, and basophil genes may provide more reproducible results...
2024: European Clinical Respiratory Journal
https://read.qxmd.com/read/38170160/a-phase-2-multicenter-open-label-study-of-anti-lag-3-ieramilimab-in-combination-with-anti-pd-1-spartalizumab-in-patients-with-advanced-solid-malignancies
#23
MULTICENTER STUDY
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S Hong, Lillian L Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel Sw Tan, Philippe A Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L Kwak, Vasileios Askoxylakis, Filippo De Braud
Ieramilimab, a humanized anti-LAG-3 monoclonal antibody, was well tolerated in combination with the anti-PD-1 antibody spartalizumab in a phase 1 study. This phase 2 study aimed to further investigate the efficacy and safety of combination treatment in patients with selected advanced (locally advanced or metastatic) solid malignancies. Eligible patients with non-small cell lung cancer (NSCLC), melanoma, renal cell carcinoma (RCC), mesothelioma, and triple-negative breast cancer (TNBC) were grouped depending on prior anti-PD-1/L1 therapy (anti-PD-1/L1 naive or anti-PD-1/L1 pretreated)...
2024: Oncoimmunology
https://read.qxmd.com/read/38147400/development-and-optimization-of-a-subtraction-normalized-immunocyte-profiling-signature-for-prostate-cancer-active-surveillance-risk-stratification
#24
JOURNAL ARTICLE
Leander Van Neste, Ricardo Henao, Kirk J Wojno, Jorge Signes, Jessica DeHart, Angela Busta, Elyse Marriott, Marian Willing, Andrea Argentini, Patrick M Hurley, Howard Korman, Jason Hafron, Mathew Putzi, Chris M Pieczonka, Lawrence I Karsh, David S Morris, Amin I Kassis, Philip W Kantoff
PURPOSE: Less invasive decision support tools are desperately needed to identify occult high-risk disease in men with prostate cancer (PCa) on active surveillance (AS). For a variety of reasons, many men on AS with low- or intermediate-risk disease forgo the necessary repeat surveillance biopsies needed to identify potentially higher-risk PCa. Here, we describe the development of a blood-based immunocyte transcriptomic signature to identify men harboring occult aggressive PCa. We then validate it on a biopsy-positive population with the goal of identifying men who should not be on AS and confirm those men with indolent disease who can safely remain on AS...
December 26, 2023: Journal of Urology
https://read.qxmd.com/read/38134587/methylation-signatures-as-biomarkers-for-non-invasive-early-detection-of-breast-cancer-a-systematic-review-of-the-literature
#25
REVIEW
Tessa Gonzalez, Qian Nie, Lubna N Chaudhary, Donald Basel, Honey V Reddi
BACKGROUND: Early detection of breast cancer would help alleviate the burden of treatment for early-stage breast cancer and help patient prognosis. There is currently no established gene panel that utilizes the potential of DNA methylation as a molecular signature for the early detection of breast cancer. This systematic review aims to identify the optimal methylation biomarkers for a non-invasive liquid biopsy assay and the gaps in knowledge regarding biomarkers for early detection of breast cancer...
December 12, 2023: Cancer Genetics
https://read.qxmd.com/read/38132144/microglial-senescence-and-activation-in-healthy-aging-and-alzheimer-s-disease-systematic-review-and-neuropathological-scoring
#26
REVIEW
Antonio Malvaso, Alberto Gatti, Giulia Negro, Chiara Calatozzolo, Valentina Medici, Tino Emanuele Poloni
The greatest risk factor for neurodegeneration is the aging of the multiple cell types of human CNS, among which microglia are important because they are the "sentinels" of internal and external perturbations and have long lifespans. We aim to emphasize microglial signatures in physiologic brain aging and Alzheimer's disease (AD). A systematic literature search of all published articles about microglial senescence in human healthy aging and AD was performed, searching for PubMed and Scopus online databases...
December 12, 2023: Cells
https://read.qxmd.com/read/38129227/habitat-radiomics-based-on-mri-for-predicting-platinum-resistance-in-patients-with-high-grade-serous-ovarian-carcinoma-a-multicenter%C3%A2-study
#27
JOURNAL ARTICLE
Qiu Bi, Kun Miao, Na Xu, Faping Hu, Jing Yang, Wenwei Shi, Ying Lei, Yunzhu Wu, Yang Song, Conghui Ai, Haiming Li, Jinwei Qiang
RATIONALE AND OBJECTIVES: This study aims to explore the feasibility of MRI-based habitat radiomics for predicting response of platinum-based chemotherapy in patients with high-grade serous ovarian carcinoma (HGSOC), and compared to conventional radiomics and deep learning models. MATERIALS AND METHODS: A retrospective study was conducted on HGSOC patients from three hospitals. K-means algorithm was used to perform clustering on T2-weighted images (T2WI), contrast-enhanced T1-weighted images (CE-T1WI), and apparent diffusion coefficient (ADC) maps...
December 21, 2023: Academic Radiology
https://read.qxmd.com/read/38068481/predicting-cardiopulmonary-arrest-with-digital-biomarkers-a-systematic-review
#28
REVIEW
Gioacchino D De Sario Velasquez, Antonio J Forte, Christopher J McLeod, Charles J Bruce, Laura M Pacheco-Spann, Karla C Maita, Francisco R Avila, Ricardo A Torres-Guzman, John P Garcia, Sahar Borna, Christopher L Felton, Rickey E Carter, Clifton R Haider
(1) Background: Telemetry units allow the continuous monitoring of vital signs and ECG of patients. Such physiological indicators work as the digital signatures and biomarkers of disease that can aid in detecting abnormalities that appear before cardiac arrests (CAs). This review aims to identify the vital sign abnormalities measured by telemetry systems that most accurately predict CAs. (2) Methods: We conducted a systematic review using PubMed, Embase, Web of Science, and MEDLINE to search studies evaluating telemetry-detected vital signs that preceded in-hospital CAs (IHCAs)...
November 30, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38032037/methods-to-increase-response-to-postal-and-electronic-questionnaires
#29
REVIEW
Philip James Edwards, Ian Roberts, Mike J Clarke, Carolyn DiGuiseppi, Benjamin Woolf, Chloe Perkins
BACKGROUND: Self-administered questionnaires are widely used to collect data in epidemiological research, but non-response reduces the effective sample size and can introduce bias. Finding ways to increase response to postal and electronic questionnaires would improve the quality of epidemiological research. OBJECTIVES: To identify effective strategies to increase response to postal and electronic questionnaires. SEARCH METHODS: We searched 14 electronic databases up to December 2021 and manually searched the reference lists of relevant trials and reviews...
November 30, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37994499/development-of-a-radiomics-model-to-discriminate-ammonium-urate-stones-from-uric-acid-stones-in-vivo-a-remedy-for-the-diagnostic-pitfall-of-dual-energy-computed-tomography
#30
JOURNAL ARTICLE
Junjiong Zheng, Jie Zhang, Jinhua Cai, Yuhui Yao, Sihong Lu, Zhuo Wu, Zhaoxi Cai, Aierken Tuerxun, Jesur Batur, Jian Huang, Jianqiu Kong, Tianxin Lin
BACKGROUND: Dual-energy computed tomography (DECT) is purported to accurately distinguish uric acid stones from non-uric acid stones. However, whether DECT can accurately discriminate ammonium urate stones from uric acid stones remains unknown. Therefore, we aimed to explore whether they can be accurately identified by DECT and to develop a radiomics model to assist in distinguishing them. METHODS: This research included two steps. For the first purpose to evaluate the accuracy of DECT in the diagnosis of uric acid stones, 178 urolithiasis patients who underwent preoperative DECT between September 2016 and December 2019 were enrolled...
November 23, 2023: Chinese Medical Journal
https://read.qxmd.com/read/37991778/clinical-and-biomarker-findings-of-neoadjuvant-pembrolizumab-and-carboplatin-plus-docetaxel-in-triple-negative-breast-cancer-neopact-phase-2-clinical-trial
#31
JOURNAL ARTICLE
Priyanka Sharma, Shane R Stecklein, Rachel Yoder, Joshua M Staley, Kelsey Schwensen, Anne O'Dea, Lauren Nye, Deepti Satelli, Gregory Crane, Rashna Madan, Maura F O'Neil, Jamie Wagner, Kelsey E Larson, Christa Balanoff, Lyndsey Kilgore, Milind A Phadnis, Andrew K Godwin, Roberto Salgado, Qamar J Khan, Joyce O'Shaughnessy
IMPORTANCE: Addition of pembrolizumab to anthracycline-based chemotherapy improves pathologic complete response (pCR) and event-free survival (EFS) in triple-negative breast cancer (TNBC). The efficacy of anthracycline-free chemoimmunotherapy in TNBC has not been assessed. OBJECTIVE: To assess the efficacy of the anthracycline-free neoadjuvant regimen of carboplatin and docetaxel plus pembrolizumab in TNBC. DESIGN, SETTING, AND PARTICIPANTS: This was an open-label phase 2 clinical trial including a single group of patients with stage I to III TNBC enrolled at 2 sites who received neoadjuvant carboplatin and docetaxel plus pembrolizumab every 21 days for 6 cycles...
February 1, 2024: JAMA Oncology
https://read.qxmd.com/read/37985312/clinical-genomic-and-transcriptomic-featurses-of-lung-adenocarcinoma-with-uncommon-egfr-mutation
#32
MULTICENTER STUDY
Kazuki Hayasaka, Haruna Takeda, Akira Sakurada, Yuki Matsumura, Jiro Abe, Satoshi Shiono, Hirotsugu Notsuda, Hiroyuki Suzuki, Makoto Endo, Hozumi Motohashi, Yoshinori Okada
PURPOSE: The purpose of this study is to identify the clinical, genomic, and transcriptomic features of patients with lung adenocarcinoma (LUAD) harboring uncommon epidermal growth factor receptor (EGFR) mutations (UCM) compared with common EGFR mutations (CM). MATERIALS AND METHODS: In this multicenter retrospective cohort study, clinicopathological data were collected from 1047 consecutive patients who underwent complete surgical resection for LUAD, as well as EGFR mutation analysis, between 2005 and 2012 at 4 institutions...
January 2024: Clinical Lung Cancer
https://read.qxmd.com/read/37955629/induction-toripalimab-and-chemotherapy-for-organ-preservation-in-locally-advanced-laryngeal-and-hypopharyngeal-cancer-a-single-arm-phase-ii-clinical-trial
#33
JOURNAL ARTICLE
Xiaomin Ou, Ruiping Zhai, Wenjun Wei, Jiaying Chen, Dan Ou, Tian Liao, Tingting Xu, Yongxue Zhu, Yulong Wang, Shenglin Huang, Rongliang Shi, Bin Wu, Tongzhen Chen, Yuan Li, Zhongyi Yang, Changming Zhou, Yuan Liu, Ziting Jiang, Min Zeng, Xin Liu, Dongmei Ji, Hongmei Ying, Zhen Zhang, Chaosu Hu, Xueguan Lu, Qinghai Ji, Xiayun He, Yu Wang
PURPOSE: The aim of this study was to assess the efficacy, toxicities, and potential role of larynx preservation of induction chemotherapy combined with programmed cell death protein 1 (PD-1) inhibitor in locally advanced laryngeal and hypopharyngeal cancer. PATIENTS AND METHODS: This is a single-arm phase II study. Patients with histopathologically confirmed, resectable locally advanced laryngeal/hypopharyngeal squamous cell carcinoma and Eastern Cooperative Oncology Group Performance Status 0-1 were eligible...
January 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/37946210/nomogram-prediction-of-the-70-gene-signature-mammaprint-binary-and-quartile-categorized-risk-using-medical-history-imaging-features-and-clinicopathological-data-among-chinese-breast-cancer-patients
#34
JOURNAL ARTICLE
Bo Pan, Ying Xu, Ru Yao, Xi Cao, Xingtong Zhou, Zhixin Hao, Yanna Zhang, Changjun Wang, Songjie Shen, Yanwen Luo, Qingli Zhu, Xinyu Ren, Lingyan Kong, Yidong Zhou, Qiang Sun
BACKGROUND: The 70-gene signature (70-GS, MammaPrint) test has been recommended by the main guidelines to evaluate prognosis and chemotherapy benefit of hormonal receptor positive human epidermal receptor 2 negative (HR + /Her2-) early breast cancer (BC). However, this expensive assay is not always accessible and affordable worldwide. Based on our previous study, we established nomogram models to predict the binary and quartile categorized risk of 70-GS. METHODS: We retrospectively analyzed a consecutive cohort of 150 female patients with HR + /Her2- BC and eligible 70-GS test...
November 9, 2023: Journal of Translational Medicine
https://read.qxmd.com/read/37935218/a-potential-prognostic-prediction-model-for-metastatic-osteosarcoma-based-on-bioinformatics-analysis
#35
JOURNAL ARTICLE
Yan Wang, Guangfu Ming, Bohua Gao
Osteosarcoma (OS) is a malignant primary bone tumor with a high incidence. This study aims to construct a prognostic prediction model by screening the prognostic mRNA of metastatic OS. Data on four eligible expression profiles from the National Center for Biotechnology Information Gene Expression Omnibus repository were obtained based on inclusion criteria and defined as the training set or the validation set. The differentially expressed genres (DEGs) between meta- static and non-metastatic OS samples in the training set were first identified, and DEGs related to prognosis were screened by univariate Cox regression analysis...
September 2023: Acta Orthopaedica Belgica
https://read.qxmd.com/read/37918414/diagnostic-accuracy-of-a-three-gene-mycobacterium-tuberculosis-host-response-cartridge-using-fingerstick-blood-for-childhood-tuberculosis-a-multicentre-prospective-study-in-low-income-and-middle-income-countries
#36
JOURNAL ARTICLE
Laura Olbrich, Valsan P Verghese, Zoe Franckling-Smith, Issa Sabi, Nyanda E Ntinginya, Alfred Mfinanga, Denise Banze, Sofia Viegas, Celso Khosa, Robina Semphere, Marriott Nliwasa, Timothy D McHugh, Leyla Larsson, Alia Razid, Rinn Song, Elizabeth L Corbett, Pamela Nabeta, Andre Trollip, Stephen M Graham, Michael Hoelscher, Christof Geldmacher, Heather J Zar, Joy Sarojini Michael, Norbert Heinrich
BACKGROUND: Childhood tuberculosis remains a major cause of morbidity and mortality in part due to missed diagnosis. Diagnostic methods with enhanced sensitivity using easy-to-obtain specimens are needed. We aimed to assess the diagnostic accuracy of the Cepheid Mycobacterium tuberculosis Host Response prototype cartridge (MTB-HR), a candidate test measuring a three-gene transcriptomic signature from fingerstick blood, in children with presumptive tuberculosis disease. METHODS: RaPaed-TB was a prospective diagnostic accuracy study conducted at four sites in African countries (Malawi, Mozambique, South Africa, and Tanzania) and one site in India...
October 30, 2023: Lancet Infectious Diseases
https://read.qxmd.com/read/37892440/gut-microbiota-composition-in-patients-with-neurodegenerative-disorders-parkinson-s-and-alzheimer-s-and-healthy-controls-a-systematic-review
#37
REVIEW
Fatemah Sadeghpour Heravi, Kaveh Naseri, Honghua Hu
This systematic review aims to provide a comprehensive understanding of the current literature regarding gut microbiota composition in patients with Parkinson's disease (PD) and Alzheimer's disease (AD) compared to healthy controls. To identify the relevant studies, a thorough search of PubMed, Medline, and Embase was conducted following the PRISMA guidelines. Out of 5627 articles, 73 studies were assessed for full-text eligibility, which led to the inclusion of 42 studies (26 PD and 16 AD studies). The risk of bias assessment showed a medium risk in 32 studies (20 PD studies and 12 AD studies), a low risk in 9 studies (5 PD studies and 4 AD studies), and 1 PD study with a high risk...
October 13, 2023: Nutrients
https://read.qxmd.com/read/37867018/radiomics-based-machine-learning-to-predict-the-recurrence-of-hepatocellular-carcinoma-a-systematic-review-and-meta-analysis
#38
REVIEW
Jin Jin, Ying Jiang, Yu-Lan Zhao, Pin-Tong Huang
RATIONALE AND OBJECTIVES: Recurrence of hepatocellular carcinoma (HCC) is a major concern in its management. Accurately predicting the risk of recurrence is crucial for determining appropriate treatment strategies and improving patient outcomes. A certain amount of radiomics models for HCC recurrence prediction have been proposed. This study aimed to assess the role of radiomics models in the prediction of HCC recurrence and to evaluate their methodological quality. MATERIALS AND METHODS: Databases Cochrane Library, Web of Science, PubMed, and Embase were searched until July 11, 2023 for studies eligible for the meta-analysis...
October 20, 2023: Academic Radiology
https://read.qxmd.com/read/37839998/dental-implant-material-related-changes-in-molecular-signatures-in-peri-implantitis-a-systematic-review-of-omics-in-vivo-studies
#39
REVIEW
Thomas Spinell, Annika Kröger, Lena Freitag, Gregor Würfl, Michael Lauseker, Reinhard Hickel, Moritz Kebschull
OBJECTIVE: Titanium particles have been shown in in-vitro studies to lead to the activation of specific pathways, this work aims to systematically review in- vivo studies examining peri-implant and periodontal tissues at the transcriptome, proteome, epigenome and genome level to reveal implant material-related processes favoring peri-implantitis development investigated in animal and human trials. METHODS: Inquiring three literature databases (Medline, Embase, Cochrane) a systematic search based on a priori defined PICOs was conducted: '-omics' studies comparing molecular signatures in healthy and infected peri-implant sites and/or healthy and periodontitis-affected teeth in animals/humans...
October 13, 2023: Dental Materials
https://read.qxmd.com/read/37813294/bioinformatic-analysis-and-verification-of-a-lipid-metabolism-related-long-noncoding-rna-prognostic-signature-for-head-and-neck-squamous-cell-carcinoma
#40
JOURNAL ARTICLE
Ling-Yu Yuan, Xun Chen, Kuang-Wu Pan, Yi He, Hong-Yu Li, Dong-Sheng Yu
PURPOSE: Both lipid metabolism reprogramming and lncRNAs exert effects on tumor development. We aimed to predict the prognosis of head and neck squamous cell carcinoma (HNSCC) based on lipid metabolism-related (LR)-lncRNAs. METHODS: LR-lncRNAs were determined from the RNA-ref profiles of HNSCC samples in The Cancer Genome Atlas (TCGA). The prognostic model was established by univariate Cox and Lasso regression analysis. Clinical relevance and predictive accuracy were investigated, and external validation was also performed in the Gene Expression Omnibus (GEO) cohort...
October 7, 2023: Cellular Signalling
keyword
keyword
78159
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.